Stephen A. Hill
2012 - Catalyst Biosciences
In 2012, Stephen A. Hill earned a total compensation of $1.2M as Former President and Chief Executive Officer at Catalyst Biosciences.
Compensation breakdown
| Option Awards | $1,180,600 |
|---|---|
| Salary | $41,666 |
| Other | $1,672 |
| Total | $1,223,938 |
Hill received $1.2M in option awards, accounting for 96% of the total pay in 2012.
Hill also received $41.7K in salary and $1.7K in other compensation.
Rankings
In 2012, Stephen A. Hill's compensation ranked 5,355th out of 11,487 executives tracked by ExecPay. In other words, Hill earned more than 53.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,355 out of 11,487 | 53rd |
Division Manufacturing | 1,880 out of 4,253 | 56th |
Major group Chemicals And Allied Products | 452 out of 1,198 | 62nd |
Industry group Drugs | 299 out of 920 | 68th |
Industry Pharmaceutical Preparations | 233 out of 700 | 67th |
Source: SEC filing on November 23, 2015.
Hill's colleagues
We found six more compensation records of executives who worked with Stephen A. Hill at Catalyst Biosciences in 2012.
2012
Jeffrey Brennan
Catalyst Biosciences
Former Senior Vice President, Business and Commercial Development and Chief Business Officer
2012
Alan Musso
Catalyst Biosciences
Chief Financial Officer
2012
Peter Zorn
Catalyst Biosciences
General Counsel
2012
J deBethizy
Catalyst Biosciences
Chief Executive Officer
2012
David Hosford
Catalyst Biosciences
Vice President, Clinical Development and Regulatory Affairs
2012
Mark Skaletsky
Catalyst Biosciences